Advancing CGM Adoption for Type 2 Diabetes Care
Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D)...
Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D)...
Imagine transforming any room into a behavioral maze that neuroscientists can use to study how the human brain processes rewards....
Diagnosed with type 1 diabetes in 1985, Hanna Boëthius faced significant struggles due to the limited tools available. Over the...
When making decisions about nutrition and diet, the focus is often on the potential impacts to the heart or brain;...
Participants of the HEARTS-D Adaptation Workshop in Sint Maarten with Dr Allana Best, Consultant, Noncommunicable Diseases and Mental Health -...